- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 479
Eli Lilly injects $53m into CureVac
The equity investment is part of a cancer vaccine development deal between the companies that could eventually reach more than $1.7bn in size.
Oct 19, 2017Aventamed tunes up $2.1m investment
The cash will allow Aventamed to seek regulatory approvals to sell its Solo earplant device in the US, having already launched in European markets.
Oct 19, 2017Heliatek re-energises with new funding
BASF, Engie and Innogy were among the investors that provided $17.6m in funding for the solar film developer, a year after doing the same for its series D round.
Oct 18, 2017Connexin secures up to $13m
The wireless internet provider has secured an investment from Cisco backed Digital Alpha to expand its team and fund a new technology centre.
Oct 18, 2017UK watchdog clears Touchstone-IP Group merger
The Competition & Markets Authority decision has allowed IP Group to confirm that its offer will become unconditional on November 9.
Oct 17, 2017UIC participants eye European horizon
The EuroIncNet partnership between UIC and four other Europe-based incubators means Sweden-based spinouts could be doing business in Austria, the Netherlands, Belgium or Italy.
Oct 16, 2017InflaRx inhales $55m in series D round
Bain Capital Life Sciences, Cormorant Asset Management and RA Capital co-led the Staidson-backed inflammatory disease drug developer's latest round.
Oct 16, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


